|Bid||0.00 x 3100|
|Ask||0.00 x 4000|
|Day's Range||68.81 - 69.73|
|52 Week Range||60.89 - 85.97|
|Beta (5Y Monthly)||0.66|
|PE Ratio (TTM)||N/A|
|Earnings Date||Oct 22, 2020 - Oct 26, 2020|
|Forward Dividend & Yield||2.72 (3.95%)|
|Ex-Dividend Date||Sep 14, 2020|
|1y Target Est||80.17|
The State of Michigan Retirement System bought more General Electric, Merck, and Intel stock in the second quarter, and sold most of its investment in biotech stock Gilead Sciences.
Amid a mixed week for chip company earnings, two semiconductor stocks got a boost from beat-and-raise reports. SiTime and Synaptics cheered investors with their results and guidance.
Pfizer signed a multi-year agreement to produce Gilead Sciences' coronavirus-treatment candidate remdesivir.